SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-048608
Filing Date
2015-08-12
Accepted
2015-08-12 17:16:47
Documents
9
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v417600_10q.htm 10-Q 468176
2 EXHIBIT 31.1 v417600_ex31-1.htm EX-31.1 6683
3 EXHIBIT 32.1 v417600_ex32-1.htm EX-32.1 3984
  Complete submission text file 0001144204-15-048608.txt   4091958

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT eyeg-20150630.xml EX-101.INS 755550
5 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20150630.xsd EX-101.SCH 42162
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20150630_cal.xml EX-101.CAL 36445
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20150630_def.xml EX-101.DEF 263421
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20150630_lab.xml EX-101.LAB 336756
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20150630_pre.xml EX-101.PRE 321853
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 151047920
SIC: 2834 Pharmaceutical Preparations